000 | 01904 a2200577 4500 | ||
---|---|---|---|
005 | 20250516093247.0 | ||
264 | 0 | _c20130115 | |
008 | 201301s 0 0 eng d | ||
022 | _a1527-3350 | ||
024 | 7 |
_a10.1002/hep.25866 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLo Re, Vincent | |
245 | 0 | 0 |
_aRisk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cNov 2012 |
||
300 |
_a1688-98 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCoinfection |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 | _aHepacivirus |
650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
650 | 0 | 4 |
_aHip Fractures _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aLiver Failure _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMedicaid _xstatistics & numerical data |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aVolk, Jessica | |
700 | 1 | _aNewcomb, Craig W | |
700 | 1 | _aYang, Yu-Xiao | |
700 | 1 | _aFreeman, Cristin P | |
700 | 1 | _aHennessy, Sean | |
700 | 1 | _aKostman, Jay R | |
700 | 1 | _aTebas, Pablo | |
700 | 1 | _aLeonard, Mary B | |
700 | 1 | _aLocalio, A Russell | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 56 _gno. 5 _gp. 1688-98 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.25866 _zAvailable from publisher's website |
999 |
_c21803556 _d21803556 |